What certifications does the product hold?

The product is certified under ISO and ISO22000 standards.

What is the lead time for orders?

The average lead time is within 15 workdays for both peak and off-season periods.

High Quality Vitamin A 99% Palmitate Powder Bulk

Name: High Quality Vitamin A 99% Palmitate Powder Bulk
Brand: Xi an Sost Biotech Co., Ltd.
SKU: 2313357095

Shaanxi, ChinaXi an Sost Biotech Co., Ltd.

US$82.00-99.00

1 kg

Sample price:US$90.00/kg.Request sample

Product profile

Customization

Available

Certification

ISO, ISO22000

Element

Vitamin E

Shape

Powder

Type

powder

Function

Vitamin Additives

Shelf Life

24 Months

Pakage

Auminum foil bag

Storage

Keep in cool, dry place

CAS No

79-81-2

Transport Package

1.1 Kilogram Per Aluminum Foil Bag with One Plast

Specification

170IU

Trademark

SOST

Origin

China

Production Capacity

300 Tons/Month

Key features

vitamin A powder is free-flowing and non-caking, making it suitable for mixing, granulation, and tableting processes, and ensuring smooth material feeding during production.

Compared to oil-based forms, it is virtually free of off-notes associated with fats or oils; it does not interfere with the flavor of the finished product and is sensorially compatible with beverages

Company profile

Xi an Sost Biotech Co., Ltd.

Shaanxi, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2012-11-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.96h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryXi'an Sost Biotech Co., Ltd. is identified as a China-based manufacturer and trading company focused on herbal extracts, Chinese medicine raw materials, cosmetic ingredients, healthcare ingredients, food additives, and dietary supplement ingredients. Evidence indicates established production, R&D, sales, purchasing, and quality-control functions, with stated GMP-oriented operations, ISO 9001:2015 certification, multiple production bases, and broad export coverage. However, the records contain conflicting production information: one slice reports three production bases and eight lines, while another reports a 2,990 m² plant and two production lines. The supplier states that it provides pre- and after-sales service and accepts several trade and payment terms, but detailed service performance, customization results, customer references, and financial strength are not sufficiently documented. Monetary figures are omitted.

Supplier typeThe supplier is explicitly classified as a manufacturer and limited company, while another record identifies its business nature as a trading company. Its stated activities include R&D, production, sales, and service of herbal extracts and natural raw materials, so it appears to combine manufacturing and trading functions.

CertificationsThe supplier reports ISO 9001:2015 certification and states that production follows national GMP standards, with GMP-standard factories and 100,000-level clean workshops. ISO certification is explicit; the GMP statements are operational claims rather than a separately named certificate.

After-Sales capabilityThe company explicitly emphasizes before-sales and after-sales service, states that it continuously improves service, and describes service as part of its business operations. However, no evidence gives measurable after-sales performance, service staffing, response times, or documented customer outcomes.

R&D capabilityThe supplier reports an R&D department, research and development of high-purity natural products, biological engineering and natural extraction technology, and an innovation-oriented approach. Nevertheless, only two years of R&D engineer experience are reported, and there is no evidence of patents, new-product records, or quantified R&D achievements.

Production capacityProduction capability is supported by a stated manufacturing plant, natural-extract production activities, GMP-oriented facilities, clean workshops, and product lines covering food, healthcare, cosmetics, and pharmaceutical intermediates. The data are inconsistent: one record states three production bases and eight lines, while another reports a 2,990 m² plant and two lines; quality-control staffing is also reported as fewer than five employees.